ESSA Pharma Ownership | Who Owns ESSA Pharma?
ESSA Pharma Ownership Summary
ESSA Pharma is owned by 0.46% institutional investors, 5.62% insiders, and 93.93% retail investors. Bvf inc/il is the largest institutional shareholder, holding 26.29% of EPIX shares. BB Biotech AG Ord is the top mutual fund, with 17.76% of its assets in ESSA Pharma shares.
EPIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ESSA Pharma | 0.46% | 5.62% | 93.93% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 11.67M | 26.29% | $2.23M |
| Soleus capital management | 4.36M | 9.83% | $833.15K |
| Morgan stanley | 1.90M | 4.29% | $363.68K |
| Pfizer | 1.68M | 3.77% | $319.93K |
| Altium capital management lp | 1.43M | 3.23% | $2.56M |
| Lmr partners llp | 540.98K | 1.22% | $103.33K |
| Shay capital | 536.53K | 1.21% | $102.48K |
| Two sigma investments, lp | 336.16K | 0.76% | $64.21K |
| Two sigma advisers, lp | 214.80K | 0.48% | $41.03K |
| Css llc/il | 103.49K | 0.23% | $19.77K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Altium capital management lp | 1.43M | 0.72% | $2.56M |
| Bvf inc/il | 11.67M | 0.09% | $2.23M |
| Pfizer | 1.68M | 0.07% | $319.93K |
| Soleus capital management | 4.36M | 0.04% | $833.15K |
| Lepercq multi-asset fund | 30.20K | 0.04% | $54.06K |
| Shay capital | 536.53K | 0.01% | $102.48K |
| Yakira capital management | 72.12K | 0.00% | $13.78K |
| Beaumont capital management | 28.23K | 0.00% | $5.39K |
| Css llc/il | 103.49K | 0.00% | $19.77K |
| Magnus financial group | 55.21K | 0.00% | $10.54K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | 11.67M | 0.09% | 2.92M |
| Soleus capital management | 4.36M | 0.04% | 2.10M |
| Altium capital management lp | 1.43M | 0.72% | 1.43M |
| Shay capital | 536.53K | 0.01% | 512.18K |
| Lmr partners llp | 540.98K | 0.00% | 340.98K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bellevue group | - | - | -7.88M |
| Tang capital management | - | - | -4.30M |
| Bml capital management | - | - | -4.22M |
| Pfm health sciences, lp | - | - | -2.74M |
| Morgan stanley | 1.90M | - | -2.31M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Altium capital management lp | 1.43M | 0.72% | 1.43M | $2.56M |
| Css llc/il | 103.49K | 0.00% | 103.49K | $19.77K |
| Virtu financial | 77.04K | 0.00% | 77.04K | $15.00K |
| Yakira capital management | 72.12K | 0.00% | 72.12K | $13.78K |
| Skandinaviska enskilda banken ab (publ) | 51.97K | - | 51.97K | $9.93K |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -48.00 |
| Laurel wealth advisors | -1.02K |
| Entrypoint capital | -4.42K |
| 49 wealth management | -11.17K |
| Millennium management | -14.05K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 12 | -72.09% | 203,192 | -99.34% | - | 0.01% | 5 | -64.29% | 1 | -87.50% |
| Jun 30, 2025 | 43 | 13.16% | 30,972,299 | -2.24% | 69 | 1.37% | 14 | 40.00% | 8 | -20.00% |
| Mar 31, 2025 | 4 | -91.67% | 13,234,768 | -59.72% | 29 | 0.54% | - | -100.00% | 1 | -80.00% |
| Dec 31, 2024 | 10 | -71.43% | 4,411,627 | -87.43% | 9 | 0.16% | 7 | -53.33% | 1 | -87.50% |
| Sep 30, 2024 | 35 | 2.94% | 35,103,052 | -0.30% | 79 | 1.25% | 15 | 87.50% | 8 | -27.27% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 7.88M | 17.76% | - |
| Rhenman Healthcare Equity L/S RC2 SEK | 804.65K | 1.81% | - |
| SQUAD Aguja Opportunities I | 500.00K | 1.13% | - |
| MEDICAL BioHealth EUR Acc | 214.80K | 0.48% | - |
| RIM Global Bioscience EUR | 54.50K | 0.12% | - |
| Avantis US Small Cap Equity ETF | 46.37K | 0.10% | - |
| Kennedy Micro Cap Opportunities | 40.85K | 0.09% | 7.46K |
| Fidelity Nasdaq Composite Index | 23.84K | 0.05% | - |
| Bellevue (Lux) Bellevue Glbl Mac I EUR | 10.00K | 0.02% | - |
| North Square Kennedy MicroCap I | 5.85K | 0.01% | 5.22K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 05, 2025 | BVF PARTNERS L P/IL | - | Sell | $148.35 |
| Aug 05, 2025 | BVF PARTNERS L P/IL | - | Sell | $20.66 |
| Aug 05, 2025 | BVF PARTNERS L P/IL | - | Sell | $123.94 |
| Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.06M |
| Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.05M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 3 |
| 2024 Q4 | - | 4 |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 2 |
| 2024 Q1 | - | 6 |
EPIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools